Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The study also found having just one moderate-to-severe concussion, or traumatic brain injury (TBI), can have a long-term impact on brain function, including memory.

Brain scans © Shutterstock

The largest study of its kind, the research included data from more than 15,000 participants of the online PROTECT study, who were aged between 50 and 90 and based in the UK. They reported the severity and frequency of concussions they had experienced throughout their lives, and completed annual, computerised tests for brain function.

Published in the Journal of Neurotrauma, the paper found that people who reported three or more concussions had significantly worse cognitive function, which got successively worse with each subsequent concussion after that. Attention and completion of complex tasks were particularly affected.

Researchers, led by teams at the University of Oxford and the University of Exeter, say people who have had concussions should be warned of the dangers of continuing high-risk sport or work.

Lead investigator Dr Vanessa Raymont, from the University of Oxford, said:

 

 

“We know that head injuries are a major risk factor for dementia, and this large-scale study gives the greatest detail to date on a stark finding - the more times you injure your brain in life, the worse your brain function could be as you age.

“Our research indicates that people who have experienced three or more even mild episodes of concussion should be counselled on whether to continue high-risk activities. We should also encourage organisations operating in areas where head impact is more likely to consider how they can protect their athletes or employees.”

The team found that participants who reported three episodes of even mild concussion throughout their lives had significantly worse attention and ability to complete complex tasks.  Those who had four or more mild concussion episodes also showed worsened processing speed and working memory. Each additional reported concussion was linked to progressively worse cognitive function.

Furthermore, the researchers found that reporting even one moderate-to-severe concussion was associated with worsened attention, completion of complex tasks and processing speed capacity.

In the online PROTECT study, participants share detailed lifestyle information, and complete a suite of cognitive tests every year, for up to 25 years. This rich mine of data helps researchers understand how the brain ages, and the factors involved in maintaining a healthier brain in later life.

Dr Helen Brooker, a study co-author from the University of Exeter, said: “As our population ages, we urgently need new ways to empower people to live healthier lives in later life. This paper highlights the importance of detailed long-term studies like PROTECT in better understating head injuries and the impact to long term cognitive function, particularly as concussion has also been linked to dementia. We’re learning that life events that might seem insignificant, life experiencing a mild concussion, can have an impact on the brain. Our findings indicate that cognitive rehabilitation should focus on key functions such as attention and completion of complex tasks, which we found to be susceptible to long-term damage.”

Dr Susan Kohlhaas, Director of Research at Alzheimer’s Research UK, said: “Studies like this are so important in unravelling the long-term risks of traumatic brain injury, including their effect on dementia risk. These findings should send a clear message to policy makers and sporting bodies, who need to put robust guidelines in place that reduce risk of head injury as much as possible.”

The PROTECT study is conducted entirely online, and is open to new participants aged 40 and over. 

The research included collaboration with University of New South Wales, Australia, Kings College London and University College London, UK, Stavanger University Hospital in Norway and Harvard Medical School, in the US.

The. paper is entitled ‘Lifetime TBI and cognitive domain deficits in late life: The PROTECT-TBI cohort study’, published in the Journal of Neurotrauma.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Dementias Platform UK secures £2.2 million funding from the Alzheimer’s Disease Data Initiative

The funding will support DPUK's work in bridging the gaps between discoveries in the lab, trials and new treatments for dementia.

Dementia research - new trial with diabetes drug

An important new trial will test the effects of oral semaglutide on the build-up of a protein in the brain that characterises Alzheimer's disease.

Alcohol affects the Human Biological Clock

The short-term effects of excessive drinking are well known, but to date it has been less certain whether alcohol also accelerates the aging process.

Moderate Drinking Linked to Brain Iron and Cognitive Decline

Consumption of seven or more units of alcohol per week is associated with higher iron levels in the brain. Iron accumulation in the brain has been linked with Alzheimer's and Parkinson's diseases and is a potential mechanism for alcohol-related cognitive decline.

Hearing Aid Use Linked to Slower Decline in Thinking Skills

A new study, co-funded by Dementias Platform UK (DPUK), has found that hearing loss increased the risk of a precursor to dementia called mild cognitive impairment, but this increased risk is not present in people who wear hearing aids.

New Clinical Trial to Test Drug for Diabetes in Reducing Risk of Alzheimer’s Dementia

A new study led through a collaboration between the Diabetes Trials Unit and the Department of Psychiatry at the University of Oxford, and the global healthcare company, Novo Nordisk, will examine whether semaglutide, a tablet used to treat diabetes, can change the course of the earliest changes that happen in the brains of people at risk of developing Alzheimer’s dementia.